Continental Choice Care, Inc. announces second quarter results.

FLORHAM PARK, N.J.--(BUSINESS WIRE)--August 15, 1996--Continental Choice Care, Inc. (NASDAQ National Market: CCCI (common): CCCIW (warrants)) ("CCCI") today announced results for the three and six month periods ended June 30, 1996. (See attached table).

In line with the Company's strategy to focus on renal dialysis, renal disease management and nephrology practice management, the Company sold its New Jersey In-Center Facility in March 1996 to generate additional working capital. The Company experienced a reduction in sales of equipment and supplies, which was only partially offset by revenues generated by the Company's new training facility in Linden, New Jersey and its new Renal Management, Inc. subsidiary ("RMI"). As a result of these factors, total net patient revenues for the three months ended June 30, 1996 declined to $1,439,419 from $2,160,395 for the same period in 1995. For the six months ended June 30, 1996, total net patient revenues declined to $3,084,769 from $4,320,842 for the same period in 1995.

The Company reported a net loss for the second quarter of $550,311, or $.17 per share, compared with a net loss of $644,445, or $.20 per share, for the comparable prior year period. The Company reported net income for the first half of 1996 of $829,263, or $.26 per share, which reflects a net gain of $1,749,080 from the sale of the New Jersey In-Center Facility in the first quarter of 1996. For the same period last year, the Company experienced a net loss of $995,750, or $.31 per share.

Steven L. Trenk, Continental Choice Care's President, stated, "We continue our focus on expanding the scope of our services in renal disease management and nephrology practice management. In this regard, we are encouraged by the continuing developments in RMI in the first six months of 1996. Our efforts to grow the business are supported by a strong balance sheet and a cash position of $2.46 million."

Continental Choice Care, Inc. is primarily engaged in providing dialysis related equipment, services and supplies to individuals in their homes and other residential alternative sites in New Jersey, New York and Connecticut, including prisons and nursing homes. The Company also provides consulting and administrative services and supplies to New York healthcare entities, as well as acute care dialysis nursing services to hospitals. Additionally, the Company owns and operates a freestanding dialysis training facility in Linden, New Jersey, which provides training and support services that enable the Company's clients to treat themselves in their homes. -0-

             CONTINENTAL CHOICE CARE, INC. AND SUBSIDIARIES
                   Consolidated Statements of Operations
                                (Unaudited)

                          For the Three Months   For the Six Months
                             Ended June 30,        Ended June 30,
                            1996      1995         1996       1995

Total net patient
 revenues               $1,439,419  $2,160,395  $3,084,769  $4,320,842

Income (loss) before
 income taxes             (539,520)   (644,445)    950,993(1) (995,750)

Provision for
 income taxes               10,791         ---     121,730        ---

Net Income (loss)       $ (550,331) $ (644,445) $  829,263 $  (995,750)

Net income (loss)
 per share              $    (.17)  $    (.20)  $      .26 $     (.31)

Weighted average
 number of
  shares outstanding     3,237,500   3,237,500    3,237,500   3,237,500

(1) Includes the gain of $1,749,080 on the sale of the former New
Jersey In-Center Facility in the first quarter of 1996.

    This press release contains forward looking statements which involve
numerous risks and uncertainties.  The Company's actual results could
differ materially from those anticipated in such forward looking
statements as a result of certain factors, including those set forth
in the Company's filings with the Securities and Exchange Commission.

CONTACT: Continental Choice Care, Inc.

Steven L. Trenk, President

[phone] ext. 130

or

INVESTOR RELATIONS COUNSEL:

The Equity Group, Inc.

Devin Sullivan, [phone]

Robert Goldstein, [phone]